On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Cytotrack ApS's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.9M · 1 project
- Horizon 2020€1.7M · 2 projects
Projects
3 EU-funded projects, newest first. Cytotrack ApS led 2 of them as coordinator. Each links to the official record.
- CytoProCoordinator
A breakthrough cancer diagnostic instrument to save 3000 years of human lives annually and up
Horizon 2020 · 2018–2021 · Project on CORDIS ↗
€1.7Mtheir share - CYTOPROCoordinator
Profiling of tumour cells in blood for personalized treatment of metastatic cancer
Horizon 2020 · 2015–2015 · Project on CORDIS ↗
€50ktheir share - CAREMOREPartner
Cancer Responsiveness Monitoring based on Resistance mutations in CTCs
FP7 (2007 to 2013) · 2013–2016 · Project on CORDIS ↗
€1.9Mtheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Erasmus Universitair Medisch Centrum RotterdamNetherlands · 1 shared project
- Stockholms UniversitetSweden · 1 shared project
- Philips Electronics Nederland BVNetherlands · 1 shared project
- Navinci Diagnostics ABSweden · 1 shared project
- Hvd Biotech Vertriebsgesellschaft MbhAustria · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- breast cancer
- colorectal cancer
- laboratory samples analysis
- mutation
- personalized medicine
- productivity
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗